Searchable abstracts of presentations at key conferences in endocrinology
ea0059cmw5.5 | Workshop 5: How do I. . . (2) | SFEBES2018
How do I know which non-diabetic patients could benefit from a GLP-1 analogue
The physiological effects of glucagon-like peptide (GLP-1) are of great interest because of their potential clinical relevance. GLP-1 is secreted by the L-cells of the distal ileum and colon in response to nutrient ingestion. It acts as an incretin hormone and augments glucose-stimulated insulin secretion in the pancreas. The use of GLP-1 agonists for the treatment of Type 2 Diabetes (T2DM) is well established. However, GLP-1 has several other physiological functions. It acts ...
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more